West Pharmaceutical Services ( NYSE: WST ) said its CFO, Bernard Birkett, will step down from his current position this year. The firm said it has started a search for a successor. Birkett joined West as CFO and senior vice president in June 2018, and in 2022, he was appointed to the combined role of chief financial and operations officer.
In April 2024, Birkett transitioned back to focusing solely on his responsibilities as the finance chief. More on West Pharmaceutical West Pharmaceutical: Remains A Strong Long-Term Prospect West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities West Pharmaceutical beats Q1 estimates.